As the IL-8/CXCR2 axis has been implicated as a therapeutic target against MDS and AML28, we examined CXCR2 expression by Q-PCR analysis in U937 and K562 cells which were co-cultured with MSCs. This evidence concerns the gene CXCR2 and myelodysplastic syndrome.